nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadodiamide—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00257	0.00257	CcSEcCtD
Gadodiamide—Somnolence—Progesterone—uterine cancer	0.00256	0.00256	CcSEcCtD
Gadodiamide—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00256	0.00256	CcSEcCtD
Gadodiamide—Bronchospasm—Etoposide—uterine cancer	0.00255	0.00255	CcSEcCtD
Gadodiamide—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00255	0.00255	CcSEcCtD
Gadodiamide—Dyspepsia—Progesterone—uterine cancer	0.00254	0.00254	CcSEcCtD
Gadodiamide—Sweating increased—Etoposide—uterine cancer	0.00252	0.00252	CcSEcCtD
Gadodiamide—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00252	0.00252	CcSEcCtD
Gadodiamide—Fatigue—Progesterone—uterine cancer	0.00248	0.00248	CcSEcCtD
Gadodiamide—Pain—Progesterone—uterine cancer	0.00246	0.00246	CcSEcCtD
Gadodiamide—Extravasation—Doxorubicin—uterine cancer	0.00246	0.00246	CcSEcCtD
Gadodiamide—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00244	0.00244	CcSEcCtD
Gadodiamide—Vasodilation—Doxorubicin—uterine cancer	0.00244	0.00244	CcSEcCtD
Gadodiamide—Cardiovascular disorder—Doxorubicin—uterine cancer	0.00244	0.00244	CcSEcCtD
Gadodiamide—Vasodilation procedure—Doxorubicin—uterine cancer	0.00244	0.00244	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00238	0.00238	CcSEcCtD
Gadodiamide—Feeling abnormal—Progesterone—uterine cancer	0.00237	0.00237	CcSEcCtD
Gadodiamide—Coordination abnormal—Epirubicin—uterine cancer	0.00236	0.00236	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Progesterone—uterine cancer	0.00236	0.00236	CcSEcCtD
Gadodiamide—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00234	0.00234	CcSEcCtD
Gadodiamide—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00233	0.00233	CcSEcCtD
Gadodiamide—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00232	0.00232	CcSEcCtD
Gadodiamide—Ill-defined disorder—Dactinomycin—uterine cancer	0.00232	0.00232	CcSEcCtD
Gadodiamide—Injection site reaction—Epirubicin—uterine cancer	0.0023	0.0023	CcSEcCtD
Gadodiamide—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.0023	0.0023	CcSEcCtD
Gadodiamide—Urticaria—Progesterone—uterine cancer	0.00229	0.00229	CcSEcCtD
Gadodiamide—Acute coronary syndrome—Etoposide—uterine cancer	0.00228	0.00228	CcSEcCtD
Gadodiamide—Body temperature increased—Progesterone—uterine cancer	0.00228	0.00228	CcSEcCtD
Gadodiamide—Abdominal pain—Progesterone—uterine cancer	0.00228	0.00228	CcSEcCtD
Gadodiamide—Eructation—Epirubicin—uterine cancer	0.00228	0.00228	CcSEcCtD
Gadodiamide—Renal failure—Etoposide—uterine cancer	0.00227	0.00227	CcSEcCtD
Gadodiamide—Myocardial infarction—Etoposide—uterine cancer	0.00227	0.00227	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Etoposide—uterine cancer	0.00227	0.00227	CcSEcCtD
Gadodiamide—Melaena—Epirubicin—uterine cancer	0.00226	0.00226	CcSEcCtD
Gadodiamide—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00225	0.00225	CcSEcCtD
Gadodiamide—Malaise—Dactinomycin—uterine cancer	0.00225	0.00225	CcSEcCtD
Gadodiamide—Coordination abnormal—Doxorubicin—uterine cancer	0.00218	0.00218	CcSEcCtD
Gadodiamide—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00215	0.00215	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00213	0.00213	CcSEcCtD
Gadodiamide—Injection site reaction—Doxorubicin—uterine cancer	0.00213	0.00213	CcSEcCtD
Gadodiamide—Myalgia—Dactinomycin—uterine cancer	0.00212	0.00212	CcSEcCtD
Gadodiamide—Hypersensitivity—Progesterone—uterine cancer	0.00212	0.00212	CcSEcCtD
Gadodiamide—Coma—Epirubicin—uterine cancer	0.00212	0.00212	CcSEcCtD
Gadodiamide—Eructation—Doxorubicin—uterine cancer	0.00211	0.00211	CcSEcCtD
Gadodiamide—Discomfort—Dactinomycin—uterine cancer	0.0021	0.0021	CcSEcCtD
Gadodiamide—Melaena—Doxorubicin—uterine cancer	0.00209	0.00209	CcSEcCtD
Gadodiamide—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00207	0.00207	CcSEcCtD
Gadodiamide—Asthenia—Progesterone—uterine cancer	0.00207	0.00207	CcSEcCtD
Gadodiamide—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00206	0.00206	CcSEcCtD
Gadodiamide—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00206	0.00206	CcSEcCtD
Gadodiamide—Urinary tract disorder—Etoposide—uterine cancer	0.00205	0.00205	CcSEcCtD
Gadodiamide—Pruritus—Progesterone—uterine cancer	0.00204	0.00204	CcSEcCtD
Gadodiamide—Oedema—Dactinomycin—uterine cancer	0.00204	0.00204	CcSEcCtD
Gadodiamide—Urethral disorder—Etoposide—uterine cancer	0.00203	0.00203	CcSEcCtD
Gadodiamide—Infection—Dactinomycin—uterine cancer	0.00202	0.00202	CcSEcCtD
Gadodiamide—Abnormal vision—Epirubicin—uterine cancer	0.00202	0.00202	CcSEcCtD
Gadodiamide—Diarrhoea—Progesterone—uterine cancer	0.00197	0.00197	CcSEcCtD
Gadodiamide—Coma—Doxorubicin—uterine cancer	0.00196	0.00196	CcSEcCtD
Gadodiamide—Phlebitis—Epirubicin—uterine cancer	0.00195	0.00195	CcSEcCtD
Gadodiamide—Flushing—Etoposide—uterine cancer	0.00193	0.00193	CcSEcCtD
Gadodiamide—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00192	0.00192	CcSEcCtD
Gadodiamide—Dizziness—Progesterone—uterine cancer	0.00191	0.00191	CcSEcCtD
Gadodiamide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00187	0.00187	CcSEcCtD
Gadodiamide—Abnormal vision—Doxorubicin—uterine cancer	0.00187	0.00187	CcSEcCtD
Gadodiamide—Chills—Etoposide—uterine cancer	0.00186	0.00186	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00186	0.00186	CcSEcCtD
Gadodiamide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00185	0.00185	CcSEcCtD
Gadodiamide—Vomiting—Progesterone—uterine cancer	0.00183	0.00183	CcSEcCtD
Gadodiamide—Renal failure acute—Epirubicin—uterine cancer	0.00182	0.00182	CcSEcCtD
Gadodiamide—Rash—Progesterone—uterine cancer	0.00182	0.00182	CcSEcCtD
Gadodiamide—Dermatitis—Progesterone—uterine cancer	0.00181	0.00181	CcSEcCtD
Gadodiamide—Phlebitis—Doxorubicin—uterine cancer	0.00181	0.00181	CcSEcCtD
Gadodiamide—Headache—Progesterone—uterine cancer	0.0018	0.0018	CcSEcCtD
Gadodiamide—Hot flush—Epirubicin—uterine cancer	0.0018	0.0018	CcSEcCtD
Gadodiamide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00179	0.00179	CcSEcCtD
Gadodiamide—Menopausal symptoms—Epirubicin—uterine cancer	0.00178	0.00178	CcSEcCtD
Gadodiamide—Dysgeusia—Etoposide—uterine cancer	0.00177	0.00177	CcSEcCtD
Gadodiamide—Renal impairment—Epirubicin—uterine cancer	0.00177	0.00177	CcSEcCtD
Gadodiamide—Fatigue—Dactinomycin—uterine cancer	0.00176	0.00176	CcSEcCtD
Gadodiamide—Pain—Dactinomycin—uterine cancer	0.00174	0.00174	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00174	0.00174	CcSEcCtD
Gadodiamide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00173	0.00173	CcSEcCtD
Gadodiamide—Cardiac failure—Epirubicin—uterine cancer	0.00172	0.00172	CcSEcCtD
Gadodiamide—Nausea—Progesterone—uterine cancer	0.00171	0.00171	CcSEcCtD
Gadodiamide—Hyponatraemia—Epirubicin—uterine cancer	0.00169	0.00169	CcSEcCtD
Gadodiamide—Renal failure acute—Doxorubicin—uterine cancer	0.00168	0.00168	CcSEcCtD
Gadodiamide—Feeling abnormal—Dactinomycin—uterine cancer	0.00168	0.00168	CcSEcCtD
Gadodiamide—Ill-defined disorder—Etoposide—uterine cancer	0.00168	0.00168	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00167	0.00167	CcSEcCtD
Gadodiamide—Hot flush—Doxorubicin—uterine cancer	0.00166	0.00166	CcSEcCtD
Gadodiamide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.00166	CcSEcCtD
Gadodiamide—Migraine—Epirubicin—uterine cancer	0.00165	0.00165	CcSEcCtD
Gadodiamide—Menopausal symptoms—Doxorubicin—uterine cancer	0.00165	0.00165	CcSEcCtD
Gadodiamide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.00165	CcSEcCtD
Gadodiamide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00164	0.00164	CcSEcCtD
Gadodiamide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00164	0.00164	CcSEcCtD
Gadodiamide—Renal impairment—Doxorubicin—uterine cancer	0.00163	0.00163	CcSEcCtD
Gadodiamide—Malaise—Etoposide—uterine cancer	0.00163	0.00163	CcSEcCtD
Gadodiamide—Abdominal pain—Dactinomycin—uterine cancer	0.00161	0.00161	CcSEcCtD
Gadodiamide—Body temperature increased—Dactinomycin—uterine cancer	0.00161	0.00161	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.00161	0.00161	CcSEcCtD
Gadodiamide—Cardiac failure—Doxorubicin—uterine cancer	0.00159	0.00159	CcSEcCtD
Gadodiamide—Loss of consciousness—Etoposide—uterine cancer	0.00159	0.00159	CcSEcCtD
Gadodiamide—Ataxia—Epirubicin—uterine cancer	0.00158	0.00158	CcSEcCtD
Gadodiamide—Blood creatinine increased—Epirubicin—uterine cancer	0.00157	0.00157	CcSEcCtD
Gadodiamide—Convulsion—Etoposide—uterine cancer	0.00156	0.00156	CcSEcCtD
Gadodiamide—Hyponatraemia—Doxorubicin—uterine cancer	0.00156	0.00156	CcSEcCtD
Gadodiamide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00155	0.00155	CcSEcCtD
Gadodiamide—Chest pain—Etoposide—uterine cancer	0.00154	0.00154	CcSEcCtD
Gadodiamide—Migraine—Doxorubicin—uterine cancer	0.00153	0.00153	CcSEcCtD
Gadodiamide—Discomfort—Etoposide—uterine cancer	0.00152	0.00152	CcSEcCtD
Gadodiamide—Hypersensitivity—Dactinomycin—uterine cancer	0.0015	0.0015	CcSEcCtD
Gadodiamide—Anaphylactic shock—Etoposide—uterine cancer	0.00147	0.00147	CcSEcCtD
Gadodiamide—Infection—Etoposide—uterine cancer	0.00146	0.00146	CcSEcCtD
Gadodiamide—Ataxia—Doxorubicin—uterine cancer	0.00146	0.00146	CcSEcCtD
Gadodiamide—Asthenia—Dactinomycin—uterine cancer	0.00146	0.00146	CcSEcCtD
Gadodiamide—Blood creatinine increased—Doxorubicin—uterine cancer	0.00146	0.00146	CcSEcCtD
Gadodiamide—Tachycardia—Etoposide—uterine cancer	0.00144	0.00144	CcSEcCtD
Gadodiamide—Hyperhidrosis—Etoposide—uterine cancer	0.00142	0.00142	CcSEcCtD
Gadodiamide—Diarrhoea—Dactinomycin—uterine cancer	0.00139	0.00139	CcSEcCtD
Gadodiamide—Hypotension—Etoposide—uterine cancer	0.00138	0.00138	CcSEcCtD
Gadodiamide—Paraesthesia—Etoposide—uterine cancer	0.00132	0.00132	CcSEcCtD
Gadodiamide—Dyspnoea—Etoposide—uterine cancer	0.00131	0.00131	CcSEcCtD
Gadodiamide—Somnolence—Etoposide—uterine cancer	0.00131	0.00131	CcSEcCtD
Gadodiamide—Vomiting—Dactinomycin—uterine cancer	0.00129	0.00129	CcSEcCtD
Gadodiamide—Rash—Dactinomycin—uterine cancer	0.00128	0.00128	CcSEcCtD
Gadodiamide—Renal failure—Epirubicin—uterine cancer	0.00127	0.00127	CcSEcCtD
Gadodiamide—Fatigue—Etoposide—uterine cancer	0.00127	0.00127	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Epirubicin—uterine cancer	0.00127	0.00127	CcSEcCtD
Gadodiamide—Pain—Etoposide—uterine cancer	0.00126	0.00126	CcSEcCtD
Gadodiamide—Feeling abnormal—Etoposide—uterine cancer	0.00121	0.00121	CcSEcCtD
Gadodiamide—Nausea—Dactinomycin—uterine cancer	0.00121	0.00121	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Etoposide—uterine cancer	0.00121	0.00121	CcSEcCtD
Gadodiamide—Renal failure—Doxorubicin—uterine cancer	0.00118	0.00118	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Doxorubicin—uterine cancer	0.00117	0.00117	CcSEcCtD
Gadodiamide—Urticaria—Etoposide—uterine cancer	0.00117	0.00117	CcSEcCtD
Gadodiamide—Rhinitis—Epirubicin—uterine cancer	0.00117	0.00117	CcSEcCtD
Gadodiamide—Body temperature increased—Etoposide—uterine cancer	0.00117	0.00117	CcSEcCtD
Gadodiamide—Abdominal pain—Etoposide—uterine cancer	0.00117	0.00117	CcSEcCtD
Gadodiamide—Pharyngitis—Epirubicin—uterine cancer	0.00115	0.00115	CcSEcCtD
Gadodiamide—Urinary tract disorder—Epirubicin—uterine cancer	0.00115	0.00115	CcSEcCtD
Gadodiamide—Urethral disorder—Epirubicin—uterine cancer	0.00114	0.00114	CcSEcCtD
Gadodiamide—Visual impairment—Epirubicin—uterine cancer	0.00112	0.00112	CcSEcCtD
Gadodiamide—Hypersensitivity—Etoposide—uterine cancer	0.00109	0.00109	CcSEcCtD
Gadodiamide—Tinnitus—Epirubicin—uterine cancer	0.00108	0.00108	CcSEcCtD
Gadodiamide—Flushing—Epirubicin—uterine cancer	0.00108	0.00108	CcSEcCtD
Gadodiamide—Rhinitis—Doxorubicin—uterine cancer	0.00108	0.00108	CcSEcCtD
Gadodiamide—Pharyngitis—Doxorubicin—uterine cancer	0.00107	0.00107	CcSEcCtD
Gadodiamide—Urinary tract disorder—Doxorubicin—uterine cancer	0.00106	0.00106	CcSEcCtD
Gadodiamide—Asthenia—Etoposide—uterine cancer	0.00106	0.00106	CcSEcCtD
Gadodiamide—Urethral disorder—Doxorubicin—uterine cancer	0.00105	0.00105	CcSEcCtD
Gadodiamide—Chills—Epirubicin—uterine cancer	0.00104	0.00104	CcSEcCtD
Gadodiamide—Pruritus—Etoposide—uterine cancer	0.00104	0.00104	CcSEcCtD
Gadodiamide—Arrhythmia—Epirubicin—uterine cancer	0.00104	0.00104	CcSEcCtD
Gadodiamide—Visual impairment—Doxorubicin—uterine cancer	0.00104	0.00104	CcSEcCtD
Gadodiamide—Diarrhoea—Etoposide—uterine cancer	0.00101	0.00101	CcSEcCtD
Gadodiamide—Tinnitus—Doxorubicin—uterine cancer	0.001	0.001	CcSEcCtD
Gadodiamide—Flushing—Doxorubicin—uterine cancer	0.000999	0.000999	CcSEcCtD
Gadodiamide—Dysgeusia—Epirubicin—uterine cancer	0.000991	0.000991	CcSEcCtD
Gadodiamide—Dizziness—Etoposide—uterine cancer	0.000975	0.000975	CcSEcCtD
Gadodiamide—Chills—Doxorubicin—uterine cancer	0.000965	0.000965	CcSEcCtD
Gadodiamide—Arrhythmia—Doxorubicin—uterine cancer	0.000961	0.000961	CcSEcCtD
Gadodiamide—Ill-defined disorder—Epirubicin—uterine cancer	0.000939	0.000939	CcSEcCtD
Gadodiamide—Vomiting—Etoposide—uterine cancer	0.000937	0.000937	CcSEcCtD
Gadodiamide—Rash—Etoposide—uterine cancer	0.000929	0.000929	CcSEcCtD
Gadodiamide—Dermatitis—Etoposide—uterine cancer	0.000928	0.000928	CcSEcCtD
Gadodiamide—Headache—Etoposide—uterine cancer	0.000923	0.000923	CcSEcCtD
Gadodiamide—Dysgeusia—Doxorubicin—uterine cancer	0.000917	0.000917	CcSEcCtD
Gadodiamide—Malaise—Epirubicin—uterine cancer	0.000913	0.000913	CcSEcCtD
Gadodiamide—Syncope—Epirubicin—uterine cancer	0.000908	0.000908	CcSEcCtD
Gadodiamide—Loss of consciousness—Epirubicin—uterine cancer	0.00089	0.00089	CcSEcCtD
Gadodiamide—Convulsion—Epirubicin—uterine cancer	0.000877	0.000877	CcSEcCtD
Gadodiamide—Nausea—Etoposide—uterine cancer	0.000875	0.000875	CcSEcCtD
Gadodiamide—Ill-defined disorder—Doxorubicin—uterine cancer	0.000869	0.000869	CcSEcCtD
Gadodiamide—Myalgia—Epirubicin—uterine cancer	0.000862	0.000862	CcSEcCtD
Gadodiamide—Chest pain—Epirubicin—uterine cancer	0.000862	0.000862	CcSEcCtD
Gadodiamide—Arthralgia—Epirubicin—uterine cancer	0.000862	0.000862	CcSEcCtD
Gadodiamide—Anxiety—Epirubicin—uterine cancer	0.000859	0.000859	CcSEcCtD
Gadodiamide—Discomfort—Epirubicin—uterine cancer	0.000851	0.000851	CcSEcCtD
Gadodiamide—Malaise—Doxorubicin—uterine cancer	0.000845	0.000845	CcSEcCtD
Gadodiamide—Dry mouth—Epirubicin—uterine cancer	0.000843	0.000843	CcSEcCtD
Gadodiamide—Syncope—Doxorubicin—uterine cancer	0.00084	0.00084	CcSEcCtD
Gadodiamide—Oedema—Epirubicin—uterine cancer	0.000826	0.000826	CcSEcCtD
Gadodiamide—Anaphylactic shock—Epirubicin—uterine cancer	0.000826	0.000826	CcSEcCtD
Gadodiamide—Loss of consciousness—Doxorubicin—uterine cancer	0.000823	0.000823	CcSEcCtD
Gadodiamide—Infection—Epirubicin—uterine cancer	0.000821	0.000821	CcSEcCtD
Gadodiamide—Shock—Epirubicin—uterine cancer	0.000813	0.000813	CcSEcCtD
Gadodiamide—Convulsion—Doxorubicin—uterine cancer	0.000812	0.000812	CcSEcCtD
Gadodiamide—Nervous system disorder—Epirubicin—uterine cancer	0.00081	0.00081	CcSEcCtD
Gadodiamide—Tachycardia—Epirubicin—uterine cancer	0.000806	0.000806	CcSEcCtD
Gadodiamide—Hyperhidrosis—Epirubicin—uterine cancer	0.000799	0.000799	CcSEcCtD
Gadodiamide—Chest pain—Doxorubicin—uterine cancer	0.000797	0.000797	CcSEcCtD
Gadodiamide—Myalgia—Doxorubicin—uterine cancer	0.000797	0.000797	CcSEcCtD
Gadodiamide—Arthralgia—Doxorubicin—uterine cancer	0.000797	0.000797	CcSEcCtD
Gadodiamide—Anxiety—Doxorubicin—uterine cancer	0.000795	0.000795	CcSEcCtD
Gadodiamide—Discomfort—Doxorubicin—uterine cancer	0.000788	0.000788	CcSEcCtD
Gadodiamide—Dry mouth—Doxorubicin—uterine cancer	0.00078	0.00078	CcSEcCtD
Gadodiamide—Hypotension—Epirubicin—uterine cancer	0.000772	0.000772	CcSEcCtD
Gadodiamide—Anaphylactic shock—Doxorubicin—uterine cancer	0.000764	0.000764	CcSEcCtD
Gadodiamide—Oedema—Doxorubicin—uterine cancer	0.000764	0.000764	CcSEcCtD
Gadodiamide—Infection—Doxorubicin—uterine cancer	0.000759	0.000759	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000753	0.000753	CcSEcCtD
Gadodiamide—Shock—Doxorubicin—uterine cancer	0.000752	0.000752	CcSEcCtD
Gadodiamide—Nervous system disorder—Doxorubicin—uterine cancer	0.00075	0.00075	CcSEcCtD
Gadodiamide—Tachycardia—Doxorubicin—uterine cancer	0.000746	0.000746	CcSEcCtD
Gadodiamide—Paraesthesia—Epirubicin—uterine cancer	0.000742	0.000742	CcSEcCtD
Gadodiamide—Hyperhidrosis—Doxorubicin—uterine cancer	0.000739	0.000739	CcSEcCtD
Gadodiamide—Dyspnoea—Epirubicin—uterine cancer	0.000737	0.000737	CcSEcCtD
Gadodiamide—Somnolence—Epirubicin—uterine cancer	0.000734	0.000734	CcSEcCtD
Gadodiamide—Dyspepsia—Epirubicin—uterine cancer	0.000727	0.000727	CcSEcCtD
Gadodiamide—Hypotension—Doxorubicin—uterine cancer	0.000714	0.000714	CcSEcCtD
Gadodiamide—Fatigue—Epirubicin—uterine cancer	0.000712	0.000712	CcSEcCtD
Gadodiamide—Pain—Epirubicin—uterine cancer	0.000706	0.000706	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000696	0.000696	CcSEcCtD
Gadodiamide—Paraesthesia—Doxorubicin—uterine cancer	0.000686	0.000686	CcSEcCtD
Gadodiamide—Dyspnoea—Doxorubicin—uterine cancer	0.000682	0.000682	CcSEcCtD
Gadodiamide—Feeling abnormal—Epirubicin—uterine cancer	0.000681	0.000681	CcSEcCtD
Gadodiamide—Somnolence—Doxorubicin—uterine cancer	0.00068	0.00068	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Epirubicin—uterine cancer	0.000676	0.000676	CcSEcCtD
Gadodiamide—Dyspepsia—Doxorubicin—uterine cancer	0.000673	0.000673	CcSEcCtD
Gadodiamide—Fatigue—Doxorubicin—uterine cancer	0.000659	0.000659	CcSEcCtD
Gadodiamide—Urticaria—Epirubicin—uterine cancer	0.000656	0.000656	CcSEcCtD
Gadodiamide—Pain—Doxorubicin—uterine cancer	0.000654	0.000654	CcSEcCtD
Gadodiamide—Abdominal pain—Epirubicin—uterine cancer	0.000653	0.000653	CcSEcCtD
Gadodiamide—Body temperature increased—Epirubicin—uterine cancer	0.000653	0.000653	CcSEcCtD
Gadodiamide—Feeling abnormal—Doxorubicin—uterine cancer	0.00063	0.00063	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000625	0.000625	CcSEcCtD
Gadodiamide—Hypersensitivity—Epirubicin—uterine cancer	0.000609	0.000609	CcSEcCtD
Gadodiamide—Urticaria—Doxorubicin—uterine cancer	0.000607	0.000607	CcSEcCtD
Gadodiamide—Body temperature increased—Doxorubicin—uterine cancer	0.000604	0.000604	CcSEcCtD
Gadodiamide—Abdominal pain—Doxorubicin—uterine cancer	0.000604	0.000604	CcSEcCtD
Gadodiamide—Asthenia—Epirubicin—uterine cancer	0.000593	0.000593	CcSEcCtD
Gadodiamide—Pruritus—Epirubicin—uterine cancer	0.000585	0.000585	CcSEcCtD
Gadodiamide—Diarrhoea—Epirubicin—uterine cancer	0.000565	0.000565	CcSEcCtD
Gadodiamide—Hypersensitivity—Doxorubicin—uterine cancer	0.000563	0.000563	CcSEcCtD
Gadodiamide—Asthenia—Doxorubicin—uterine cancer	0.000548	0.000548	CcSEcCtD
Gadodiamide—Dizziness—Epirubicin—uterine cancer	0.000546	0.000546	CcSEcCtD
Gadodiamide—Pruritus—Doxorubicin—uterine cancer	0.000541	0.000541	CcSEcCtD
Gadodiamide—Vomiting—Epirubicin—uterine cancer	0.000525	0.000525	CcSEcCtD
Gadodiamide—Diarrhoea—Doxorubicin—uterine cancer	0.000523	0.000523	CcSEcCtD
Gadodiamide—Rash—Epirubicin—uterine cancer	0.000521	0.000521	CcSEcCtD
Gadodiamide—Dermatitis—Epirubicin—uterine cancer	0.00052	0.00052	CcSEcCtD
Gadodiamide—Headache—Epirubicin—uterine cancer	0.000518	0.000518	CcSEcCtD
Gadodiamide—Dizziness—Doxorubicin—uterine cancer	0.000505	0.000505	CcSEcCtD
Gadodiamide—Nausea—Epirubicin—uterine cancer	0.000491	0.000491	CcSEcCtD
Gadodiamide—Vomiting—Doxorubicin—uterine cancer	0.000486	0.000486	CcSEcCtD
Gadodiamide—Rash—Doxorubicin—uterine cancer	0.000482	0.000482	CcSEcCtD
Gadodiamide—Dermatitis—Doxorubicin—uterine cancer	0.000482	0.000482	CcSEcCtD
Gadodiamide—Headache—Doxorubicin—uterine cancer	0.000479	0.000479	CcSEcCtD
Gadodiamide—Nausea—Doxorubicin—uterine cancer	0.000454	0.000454	CcSEcCtD
